Abstract:Cancer immunotherapy using cytotoxic T cells demonstrates dramatic survival benefits in lymphomas, but its efficacy in solid tumors is limited. Here, we investigated the possibility of using cytotoxic T cells to treat malignant Schwannoma, a rare but aggressive nerve sheath tumor, by examining the native T-cell immunity in the host. We found that compared to CD8+ T cells from healthy controls or benign Schwannoma patients, the CD8+ T cells from malignant Schwannoma patients were present at normal frequencies but were substantially enriched with PD-1-TIM-3+ and PD-1+TIM-3+ cells. Compared to the PD-1-TIM-3- CD8+ T cells, the PD-1-TIM-3+ and PD-1+TIM-3+ CD8+ T cells presented significantly lower proliferation capacity, reduced interleukin 2 and interferon gamma expression, and/or dramatically decreased perforin and granzyme B secretion, indicating a whole-spectrum immunosuppression and reduced cytotoxicity. TIM-3 expression alone was associated with lower proliferation and less perforin and granzyme B secretion, whereas PD-1 expression alone was not associated with functional impairments, suggesting that TIM-3 expression was a better marker of exhausted CD8+ T cells. The expression of galectin 9, a TIM-3 ligand, in CD4+ Th cells was significantly elevated in malignant, but not benign, Schwannoma patients and were enriched in CD25+ Treg cells. Both the PD-1-TIM-3+ and PD-1+TIM-3+ CD8+ T cells responded to Treg-mediated and galectin 9-mediated suppression, whereas the PD-1+TIM-3- CD8+ T cells only responded to Treg-mediated suppression. In resected tumors, the malignant Schwannomas had more tumor-infiltrating CD4+ and CD8+ T cells than the benign Schwannomas, but a large fraction of these tumor-infiltrating CD4+ and CD8+ T cells expressed PD-1 and/or TIM-3, which indicated that their antitumor immunity was compromised. Together, our results suggested that PD-1 and TIM-3 blockade might be necessary in developing effective immunotherapeutic strategies in malignant Schwannoma, in which TIM-3 may play a more important role.

Dysregulation Of Il-10 By Macrophages And T Cells In Recurrent And Malignant Schwannomas

Malignant Transformation of Benign Intraosseous Schwannoma in the Cervical Spine: a Case Report with an Immunohistochemical Study.

Epigenetic reprogramming shapes the cellular landscape of schwannoma

TIM-3 plays a more important role than PD-1 in the functional impairments of cytotoxic T cells of malignant Schwannomas

Comprehensive analysis of diagnosis and treatment in 99 cases of abdominal Schwannoma

Schwann Cells Promote Lung Cancer Proliferation by Promoting the M2 Polarization of Macrophages.

Recurrent Retroperitoneal Schwannomas Displaying Different Differentiation from Primary Tumor: Case Report and Literature Review

Schwann cells in the normal and pathological lung microenvironment

Interleukin 33 in Tumor Microenvironment is Crucial for the Accumulation and Function of Myeloid-Derived Suppressor Cells

Expression of miR-10b gene and methylation level in schwannomas

Schwann Cell‐Mediated M2‐Like Macrophage Polarization in Rhabdomyosarcoma

Therapeutic Effect and Prognostic Analysis of 31 Cases with Malignant Schwannoma

Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment

Tissue-resident glial cells associate with tumoral vasculature and promote cancer progression

Interrogation of the Microenvironmental Landscape in Spinal Ependymomas Reveals Dual Functions of Tumor-Associated Macrophages.

Extramedullary Melanotic Schwannoma Recurrence in the Cervical Vertebral Arch: a Case Report and Review of the Literature

Molecular Features of a Primary Transmural Tracheal Schwannoma: Clinical Experience and Review of the Literature

Retracted: MicroRNA‐29a Inhibits Proliferation and Motility of Schwannoma Cells by Targeting CDK6

Myeloid-derived Suppressor Cells and Nonresolving Inflammatory Cells in Glioma Microenvironment: Molecular Mechanisms and Therapeutic Strategies

Pancreatic Schwann cell reprogramming supports cancer-associated neuronal remodeling

IL-10 secreted by M2 macrophage promoted tumorigenesis through interaction with JAK2 in glioma